Herbal medicines use and associated factors among pregnant women in Debre Tabor town, north West Ethiopia: a mixed method approach

Addis, Getu Tesfaw; Workneh, Birhanu Demeke; Kahissay, Mesfin Haile

doi:10.1186/s12906-021-03439-3

Cited by 12 publications

(11 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Nevertheless, consistent with previous ndings, the primary reason for non-disclosure of T/CM use was the lack of inquiry from obstetric care providers, while the majority of T/CM users were willing to disclose their use if the conversation was initiated by their providers 19,[53][54][55] . These ndings emphasize the importance of healthcare providers' role in promoting effective communication about various healthcare approaches, including T/CM, to ensure patient safety and health.…”

Section: Discussionsupporting

confidence: 80%

Patient-physician communication on the use of traditional and complementary medicine during the COVID-19 outbreak: A cross-sectional study on pregnant women in Bolivia

Im,

Hwang,

Jung

et al. 2023

Preprint

View full text Add to dashboard Cite

During the coronavirus disease 2019 (COVID-19) pandemic, many individuals sought traditional and complementary medicine (T/CM) as an alternative to conventional healthcare, while also adhering to social distancing guidelines. Consequently, understanding the T/CM use among vulnerable populations, specifically pregnant women, and the communication practices between patients and healthcare providers regarding its use is crucial. This study assessed T/CM use among pregnant women in El Alto, Bolivia, during the COVID-19 outbreak and examined communication behaviors regarding T/CM use during antenatal consultations. A 48-item semi-structured survey was used to conduct a descriptive cross-sectional study of 271 postpartum women in two public hospitals in El Alto. Data analysis included chi-squared tests and logistic regression in SPSS ver. 26.0. Although 57% of women reported using T/CM during pregnancy, less than one-third of these women discussed their T/CM use with healthcare providers. However, over 70% of women were willing to disclose T/CM use if the discussion was initiated by healthcare providers. Potential predictors of T/CM disclosure included non-use of nutritional supplements during pregnancy and obtaining T/CM-related information from the mass media. Our findings highlight a significant communication gap between pregnant women and healthcare providers regarding T/CM use, despite their widespread use during public health crises such as COVID-19. Therefore, it is critical to develop interventions to improve communication practices and enhance the quality of care for pregnant women.

show abstract

Section: Discussionsupporting

confidence: 80%

Patient-physician communication on the use of traditional and complementary medicine during the COVID-19 outbreak: A cross-sectional study on pregnant women in Bolivia

Im,

Hwang,

Jung

et al. 2023

Preprint

View full text Add to dashboard Cite

show abstract

“…Among 111 studies, 102 studies were cross-sectional in design 27 61–161. Three studies used mixed-method approaches,162–164 and six studies had non-cross-sectional designs (ie, longitudinal and case–control),165–170 but reported cross-sectional data on HM use during pregnancy (online supplemental appendix 6). Regarding the geographical distribution of included studies, a majority of them were conducted in Africa 66 69 77 81 82 89 91 95 98 100 101 105 106 115 116 119 121–123 129 132–135 137–140 143 144 146 150 153 156 158–164.…”

Section: Resultsmentioning

confidence: 99%

“…Three studies used mixed-method approaches,162–164 and six studies had non-cross-sectional designs (ie, longitudinal and case–control),165–170 but reported cross-sectional data on HM use during pregnancy (online supplemental appendix 6). Regarding the geographical distribution of included studies, a majority of them were conducted in Africa 66 69 77 81 82 89 91 95 98 100 101 105 106 115 116 119 121–123 129 132–135 137–140 143 144 146 150 153 156 158–164. Lastly, 21 out of 111 studies presented findings related to pregnant women’s disclosure of HM use to their healthcare providers 27 70 73 83 85 86 91 109 110 115 117 122 125 126 129 133 142 149 155 160 164…”

Section: Resultsmentioning

confidence: 99%

“…Regarding the geographical distribution of included studies, a majority of them were conducted in Africa 66 69 77 81 82 89 91 95 98 100 101 105 106 115 116 119 121–123 129 132–135 137–140 143 144 146 150 153 156 158–164. Lastly, 21 out of 111 studies presented findings related to pregnant women’s disclosure of HM use to their healthcare providers 27 70 73 83 85 86 91 109 110 115 117 122 125 126 129 133 142 149 155 160 164…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Patient–physician communication on herbal medicine use during pregnancy: a systematic review and meta-analysis

Im,

Hwang,

Choi

et al. 2024

BMJ Glob Health

View full text Add to dashboard Cite

IntroductionLack of transparent communication between patients and physicians regarding the use of herbal medicine (HM) presents a major public health challenge, as inappropriate HM use poses health risks. Considering the widespread use of HM and the risk of adverse events, it is crucial for pregnant women to openly discuss their HM use with healthcare providers. Therefore, this systematic review and meta-analysis aims to estimate the pooled prevalence of pregnant women’s HM use and disclosure to healthcare providers and to examine the relationship between HM disclosure and various maternal and child health (MCH) measures.MethodsA systematic search of five databases was conducted for cross-sectional studies on HM use during pregnancy published from 2000 to 2023. Data extraction followed a standardised approach, and Stata V.16.0 was used for data analysis. Also, Spearman’s correlation coefficient was calculated to examine the association between use and disclosure of HM and various MCH indicators.ResultsThis review included 111 studies across 51 countries on the use of HM among pregnant women. Our findings showed that 34.4% of women used HM during pregnancy, driven by the perception that HM is presumably safer and more natural than conventional medical therapies. However, only 27.9% of the HM users disclosed their use to healthcare providers because they considered HM as harmless and were not prompted by the healthcare providers to discuss their self-care practices. Furthermore, a significant correlation was observed between HM disclosure and improved MCH outcomes.ConclusionInadequate communication between pregnant women and physicians on HM use highlights a deficiency in the quality of care that may be associated with unfavourable maternal outcomes. Thus, physician engagement in effective and unbiased communication about HM during antenatal care, along with evidence-based guidance on HM use, can help mitigate the potential risks associated with inappropriate HM use.

show abstract

“…Pregnant women usually do not consult the use of herbs with a doctor or pharmacist [ 6 ]. Data demonstrated that almost 95% of Ethiopian pregnant women did not consult the usage of herbal medicines with the doctor or nurse [ 7 ]. In Norway, only less than 12% of pregnant women were recommended to use herbs by healthcare personnel [ 8 ].…”

Section: Introductionmentioning

confidence: 99%

Herbal Medicines—Are They Effective and Safe during Pregnancy?

Sarecka-Hujar

Szulc-Musioł

2022

Pharmaceutics

View full text Add to dashboard Cite

Since the teratogenicity of Thalidomide has been proven, herbal products are more commonly used in pregnancy to not only relieve morning sickness but also to fight infections. These products are frequently considered as natural and therefore harmless. However, herbs contain a number of active substances that, when used during pregnancy, can affect the development of the fetus. Often, pregnant women do not consult the usage of herbal medicines with a physician. The access to these products is easy and treatment of certain ailments with the use of herbs is common in many countries. The aim of the present literature review was to discuss available data regarding the efficacy and safety of cranberry, chamomile, Echinacea purpurea, garlic, ginger, Ginkgo biloba, and peppermint, which are used to counteract the most common ailments during pregnancy, i.e., infections and pregnancy-related ailments (e.g., nausea and vomiting, dizziness, and headache). Analysis of available data showed that ginger is one of the most extensively analyzed herbal remedies. The dose of ginger below 1000 mg per day may help to relief hypereremesis gravidarum, and such an amount of ginger did not increase frequency of adverse effects for either woman or developing fetus. Data regarding other herbs are most often heterogeneous and give conflicting results with no clear conclusions. However, all herbal products should be used with a special caution in pregnancy. Further high-quality human studies should be determined to confirm the safe doses of herbal products which could be used by pregnant or breast-feeding women.

show abstract

Herbal medicines use and associated factors among pregnant women in Debre Tabor town, north West Ethiopia: a mixed method approach

Cited by 12 publications

References 17 publications

Patient-physician communication on the use of traditional and complementary medicine during the COVID-19 outbreak: A cross-sectional study on pregnant women in Bolivia

Patient-physician communication on the use of traditional and complementary medicine during the COVID-19 outbreak: A cross-sectional study on pregnant women in Bolivia

Patient–physician communication on herbal medicine use during pregnancy: a systematic review and meta-analysis

Herbal Medicines—Are They Effective and Safe during Pregnancy?

Contact Info

Product

Resources

About